Literature DB >> 26337020

Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.

Ji Won Choi1, Bo Ko Jang2, Nam-chul Cho3, Jong-Hyun Park3, Seul Ki Yeon3, Eun Ji Ju3, Yong Sup Lee4, Gyoonhee Han5, Ae Nim Pae6, Dong Jin Kim3, Ki Duk Park7.   

Abstract

We have synthesized three categories of α,β-unsaturated carbonyl derivatives and evaluated their MAO-A and MAO-B inhibitory activities. Among them, compound 10b including α,β-unsaturated ketone group showed the most potent and selective MAO-B inhibitory activity (IC₅₀ human MAO-B 16 nM, >6000-fold selective vs MAO-A) and compound 10b exhibited good reversibility compared with selegiline, a well-known irreversible MAO-B inhibitor. However, both α,β-unsaturated amide and ester derivatives exhibited weaker MAO-B inhibition potencies. The docking studies provided insights into the possible binding modes and the key interaction sites of the synthesized MAO-B inhibitors.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chalcone; MAO-B inhibitor; Monoamine oxidase; Reversible inhibitor; α,β-Unsaturated carbonyl derivatives

Mesh:

Substances:

Year:  2015        PMID: 26337020     DOI: 10.1016/j.bmc.2015.08.012

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  14 in total

1.  Design, Synthesis, and Biological Evaluation of Novel Allosteric Protein Disulfide Isomerase Inhibitors.

Authors:  Suhui Yang; Andrea Shergalis; Dan Lu; Anahita Kyani; Ziwei Liu; Mats Ljungman; Nouri Neamati
Journal:  J Med Chem       Date:  2019-04-02       Impact factor: 7.446

2.  Ciproxifan, a histamine H3 receptor antagonist, reversibly inhibits monoamine oxidase A and B.

Authors:  S Hagenow; A Stasiak; R R Ramsay; H Stark
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

3.  Design and Synthesis of New Benzothiazole Compounds as Selective hMAO-B Inhibitors.

Authors:  Sinem Ilgın; Derya Osmaniye; Serkan Levent; Begüm Nurpelin Sağlık; Ulviye Acar Çevik; Betül Kaya Çavuşoğlu; Yusuf Özkay; Zafer Asım Kaplancıklı
Journal:  Molecules       Date:  2017-12-09       Impact factor: 4.411

4.  Synthesis and Biological Evaluation of New Thiosemicarbazone Derivative Schiff Bases as Monoamine Oxidase Inhibitory Agents.

Authors:  Betül Kaya Çavuşoğlu; Begüm Nurpelin Sağlık; Derya Osmaniye; Serkan Levent; Ulviye Acar Çevik; Abdullah Burak Karaduman; Yusuf Özkay; Zafer Asım Kaplancıklı
Journal:  Molecules       Date:  2017-12-28       Impact factor: 4.411

5.  Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease.

Authors:  Jong-Hyun Park; Yeon Ha Ju; Ji Won Choi; Hyo Jung Song; Bo Ko Jang; Junsung Woo; Heejung Chun; Hyeon Jeong Kim; Su Jeong Shin; Oleg Yarishkin; Seonmi Jo; Mijeong Park; Seul Ki Yeon; Siwon Kim; Jeongyeon Kim; Min-Ho Nam; Ashwini M Londhe; Jina Kim; Sung Jin Cho; Suengmok Cho; Changho Lee; Sung Yeoun Hwang; Sang Wook Kim; Soo-Jin Oh; Jeiwon Cho; Ae Nim Pae; C Justin Lee; Ki Duk Park
Journal:  Sci Adv       Date:  2019-03-20       Impact factor: 14.136

6.  Computational Studies Applied to Flavonoids against Alzheimer's and Parkinson's Diseases.

Authors:  Alex France M Monteiro; Jéssika De O Viana; Anuraj Nayarisseri; Ernestine N Zondegoumba; Francisco Jaime B Mendonça Junior; Marcus Tullius Scotti; Luciana Scotti
Journal:  Oxid Med Cell Longev       Date:  2018-12-30       Impact factor: 6.543

7.  Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors.

Authors:  Jong Min Oh; T M Rangarajan; Reeta Chaudhary; Rishi Pal Singh; Manjula Singh; Raj Pal Singh; Anna Rita Tondo; Nicola Gambacorta; Orazio Nicolotti; Bijo Mathew; Hoon Kim
Journal:  Molecules       Date:  2020-05-18       Impact factor: 4.411

8.  Neuron-based high-content assay and screen for CNS active mitotherapeutics.

Authors:  Boglarka H Varkuti; Miklos Kepiro; Ze Liu; Kyle Vick; Yosef Avchalumov; Rodrigo Pacifico; Courtney M MacMullen; Theodore M Kamenecka; Sathyanarayanan V Puthanveettil; Ronald L Davis
Journal:  Sci Adv       Date:  2020-01-08       Impact factor: 14.136

9.  Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders.

Authors:  Payyalot Koyiparambath Vishal; Jong Min Oh; Ahmed Khames; Mohamed A Abdelgawad; Aathira Sujathan Nair; Lekshmi R Nath; Nicola Gambacorta; Fulvio Ciriaco; Orazio Nicolotti; Hoon Kim; Bijo Mathew
Journal:  Pharmaceutics       Date:  2021-06-08       Impact factor: 6.321

10.  Discovery of N-(1-(3-fluorobenzoyl)-1H-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B.

Authors:  Ahmed Elkamhawy; Sora Paik; Hyeon Jeong Kim; Jong-Hyun Park; Ashwini M Londhe; Kyeong Lee; Ae Nim Pae; Ki Duk Park; Eun Joo Roh
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.